Maheshwari D.G.
References
8. References 1. Tripathi KD. Essentials of medical pharmacology. 5th ed. New Delhi: Jaypee Brothers Medical Publishers Pvt. Ltd.; 2004. p. 599-600. 2. Rang HP, Dale MM, Ritter JM, Moore PK. Rang and Dale’s pharmacology. 5 th ed. New Delhi: Elsevier; 2005. p. 372-375. 3. Rang HP, Dale MM, Ritter JM, and Flower RJ. Rang and Dale’s pharmacology. 6th ed. London: Elsevier; 2008. p. 189-196. 4. Tripathi KD. Essentials of medical pharmacology. 5th ed. New Delhi: Jaypee Brothers Medical Publishers Pvt. Ltd.; 2004. p. 141-151. 5. Fauci KB, Jameson HL. Harrison’s principle of internal medicine. 16th ed. New York: Mc Graw-Hill; 2005. p. 90-91. 6. Satoskar RS, Bhandarkar SD, Rege NN. Pharmacology and pharmacotherapeutics. 19 th ed. Mumbai: Popular Prakashan Pvt. Ltd.; 2005. p. 324-326. 7. Siddiqui HH. Essentials of medical pharmacology. 1st ed. New Delhi: Globalmedik; 2010. p. 133-136. 8. Goyal RK, Mehta AA, Balaraman R, Burande MD. Derasari and Gandhi’s elements of pharmacology. 5th ed. Ahmedabad: B S Shah Prakashan; 2005-2006. p. 142-144. 9. Dandiya PC, Kulkarni SK. Introduction to pharmacology. 6th ed. Delhi: Vallabh Prakashan; 2007. p. 255, 393-394. 10. Budhiraja RD. Elementary pharmacology and toxicology. 4th ed. Mumbai: Popular Prakashan Pvt. Ltd.; 2009. p. 209-211. 11. Harvey RA, Champe PC, Howland RD, Mycek MJ. Lippincott’s illustrated reviews pharmacology. 3rd ed. Philadelphia: Lippincott Williams and Wilkins; 2006. p. 330-331. 12. Block JH, Beale JM. Wilson and Gisvold’s textbook of organic medical and pharmaceutical chemistry. 11th ed. Philadelphia: Lippincott Williams and Wilkins; 2004. p. 518-520. 13. The Merck Index. 14th ed. White house station, NJ, USA: Published by Merck Research Laboratories, Division of Merck & Co., INC.; 2006. p. 1179. ––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––– L.J.I.P Kadi Sarva Vishwavidyalaya 129
Maheshwari D.G.
References
14. The Merck Index. 14th ed. White house station, NJ, USA: Published by Merck Research Laboratories, Division of Merck & Co., INC.; 2006. p. 782-783. 15. Dandiya PC, Kulkarni SK. Introduction to pharmacology. 6th ed. Delhi: Vallabh Prakashan; 2007. p. 257. 16. Harvey RA, Champe PC, Howland RD, Mycek MJ. Lippincott’s illustrated reviews pharmacology. 3rd ed. Philadelphia: Lippincott Williams and Wilkins; 2006. p. 126, 323. 17. Bele V. Pharmacology. 1st ed. Nashik: Career Publications; 2006. p. 210-211. 18. Fauci KB, Jameson HL. Harrison’s principle of internal medicine. 16th ed. New York: Mc Graw-Hill; 2005. p. 221. 19. Tripathi KD. Essentials of medical pharmacology. 5th ed. New Delhi: Jaypee Brothers Medical Publishers Pvt. Ltd.; 2004. p. 206-207. 20. Tripathi KD. Essentials of medical pharmacology. 4th ed. New Delhi: Jaypee Brothers Medical Publishers Pvt. Ltd.; 1999. p. 190, 651. 21. Rang HP, Dale MM, Ritter JM, Moore PK. Pharmacology. 5th ed. New Delhi: Elsevier; 2005. p. 368-371. 22. Singh H, Kapoor VK. Medicinal and pharmaceutical chemistry. 2 nd ed. Delhi: Vallabh Prakashan; 2009. p. 234-236. 23. The Merck Index. 14th ed. White house station, NJ, USA: Published by Merck Research Laboratories, Division of Merck & Co., INC.; 2006. p. 1179-1180. 24. The Merck Index. 14th ed. White house station, NJ, USA: Published by Merck Research Laboratories, Division of Merck & Co., INC.; 2006. p. 1392. 25. The Merck Index. 14th ed. White house station, NJ, USA: Published by Merck Research Laboratories, Division of Merck & Co., INC.; 2006. p. 1209-1210. 26. Fauci KB, Jameson HL. Harrison’s principle of internal medicine. 16 th ed. Mc Graw-Hill; 2005. p. 223.
––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––– L.J.I.P Kadi Sarva Vishwavidyalaya 130
Maheshwari D.G.
References
27. Kadam SS, Mahadik KR, Bothara KG. Principles of medicinal chemistry. Volume-I. 17th ed. Pune: Nirali Prakashan; 2007. p. 264. 28. Tripathi KD. Essentials of medical pharmacology. 5th ed. New Delhi: Jaypee Brothers Medical Publishers Pvt. Ltd.; 2004. p. 631-632. 29. Dandiya PC, Kulkarni SK. Introduction to pharmacology. 6th ed. Delhi: Vallabh Prakashan; 2007. p. 252. 30. Budhiraja RD. Elementary pharmacology and toxicology. 4th ed. Mumbai: Popular Prakashan Pvt. Ltd.; 2009. p. 349. 31. Harvey RA, Champe PC, Howland RD, Mycek MJ. Lippincott’s illustrated reviews pharmacology. 3rd ed. Philadelphia: Lippincott Williams and Wilkins; 2006. p. 15, 326-327, 499, 516. 32. Block JH, Beale JM. Wilson and Gisvold’s textbook of organic medical and pharmaceutical chemistry. 11th ed. Philadelphia: Lippincott Williams and Wilkins; 2004. p. 722-726. 33. Goyal RK, Mehta AA, Balaraman R, Burande MD. Derasari and Gandhi’s elements of pharmacology. 5th ed. Ahmedabad: B S Shah Prakashan; 2005-2006. p. 441-442. 34. Siddiqui HH. Essentials of medical pharmacology. 1st ed. New Delhi: Globalmedik; 2010. p. 339-340. 35. Bele V. Pharmacology. 1st ed. Nashik: Career Publications; 2006. p. 202, 205-206. 36. Satoskar RS, Bhandarkar SD, Rege NN. Pharmacology and pharmacotherapeutics. 19 th ed. Mumbai: Popular Prakashan Pvt. Ltd.; 2005. p. 620-621. 37. Kadam SS, Mahadik KR, Bothara KG. Principles of medicinal chemistry. Volume-I. 17th ed. Pune: Nirali Prakashan; 2007. p. 259-263. 38. Tripathi KD. Essentials of medical pharmacology. 5th ed. New Delhi: Jaypee Brothers Medical Publishers Pvt. Ltd.; 2004. p. 588, 593. 39. Satoskar RS, Bhandarkar SD, Rege NN. Pharmacology and pharmacotherapeutics. 19 th ed. Mumbai: Popular Prakashan Pvt. Ltd.; 2005. p. 588-592. ––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––– L.J.I.P Kadi Sarva Vishwavidyalaya 131
Maheshwari D.G.
References
40. Bele V. Pharmacology. 1st ed. Nashik: Career Publications; 2006. p. 206-210. 41. http://www.livestrong.com/article/232329-what-is-a-dopamine-antagonist 42. The Merck Index. 14th ed. White house station, NJ, USA: Published by Merck Research Laboratories, Division of Merck & Co., INC.; 2006. p. 1058-1059. 43. The Merck Index. 14th ed. White house station, NJ, USA: Published by Merck Research Laboratories, Division of Merck & Co., INC.; 2006. p. 578-579. 44. Budhiraja RD. Elementary pharmacology and toxicology. 4th ed. Mumbai: Popular Prakashan Pvt. Ltd.; 2009. p. 357. 45. Goyal RK, Mehta AA, Balaraman R, Burande MD. Derasari and Gandhi’s elements of pharmacology. 5th ed. Ahmedabad: B S Shah Prakashan; 2005-2006. p. 293, 443, 449. 46. Siddiqui HH. Essentials of medical pharmacology. 1st ed. New Delhi: Globalmedik; 2010. p. 138, 356-357. 47. Siddiqui AA, Ramakrishna N, Jain SK. Pharmacology and toxicology. 1st ed. New Delhi: Birla Publications; 2006-07. p. 149. 48. Siddiqui HH. Essentials of medical pharmacology. 1st ed. New Delhi: Globalmedik; 2010. p. 297-300. 49. Satoskar RS, Bhandarkar SD, Rege NN. Pharmacology and pharmacotherapeutics. 19th ed. Mumbai: Popular Prakashan Pvt. Ltd.; 2005. p. 101, 194. 50. Block JH, Beale JM. Wilson and Gisvold’s textbook of organic medical and pharmaceutical chemistry. 11th ed. Philadelphia: Lippincott Williams and Wilkins; 2004. p. 501. 51. Tripathi KD. Essentials of medical pharmacology. 4th ed. New Delhi: Jaypee Brothers Medical Publishers Pvt. Ltd.; 2002. p. 354, 405, 409. 52. Singh H, Kapoor VK. Medicinal and pharmaceutical chemistry. 2 nd ed. Delhi: Vallabh Prakashan; 2009. p. 142, 144. 53. Fujii Y, Toyooka H, Tanaka H. A Granisetron-Droperidol combination prevents postoperative vomiting in children. Anesthesia and Analgia 1998; 87: 761-765. ––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––– L.J.I.P Kadi Sarva Vishwavidyalaya 132
Maheshwari D.G.
References
54. Kocamanoglu IS, Baris S, Karakaya D, Sener B, Tur A, Cetinkaya M. The effects of Granisetron with Droperidol or Dexamethasone on prevention of postoperative nausea and vomiting after general anesthesia for cesarean section. Methods and Findings of Experimental Clinical Pharmacology 2005; 27(7): 489. 55. Mustacchi G, Ceccherini R, Leita ML, Sandri P, Milani S, Carbonara T. The combination of Metoclopramide, Methylprednisolone and Ondansetron against antiblastic-delayed emesis: a randomized phase II study. Anticancer Research 1997; 17(2B): 1345-1348. 56. Aravantinos G, Sgouros I, Kostopoulou M, Kostopoulos V. A combination of Ondansetron, Metoclopramide, Dexamethasone and Lorazepam for the prevention of irinotecan induced nausea and vomiting. Austral-Asian Journal of Cancer 2005; 4(2): 87-90. 57. Guidance for industry. Analytical procedure and method validation chemistry, manufacturing and controls documentation. Rockville, Maryland: U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER) and Center for Veterinary Medicine (CVM); 2004. 58. ICH guideline Q1A(R2). Stability testing of new drug substances and products. Geneva: 2003. 59. United States Pharmacopoeia. 26th ed. Rockville, MD: US Pharmacopoeial Convention Inc.; 2003. p. 1151. 60. Munson JW. High performance liquid chromatography: theory, instrumentation and pharmaceutical applications. New York: Marcel Dekker Inc.; 2001. p. 16-17. 61. United States Pharmacopoeia. 24th ed. Rockville, MD: United States Pharmacopoeial Convention Inc.; 2000. p. 1923. 62. ICH guideline Q2(R1). Validation of analytical procedures: text and methodology. Geneva: 1996. 63. Guidance for industry. Bioanalytical method validation. Rockville, Maryland: U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER) and Center for Veterinary Medicine (CVM); 2001. ––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––– L.J.I.P Kadi Sarva Vishwavidyalaya 133
Maheshwari D.G.
References
64. Bolton S, Charles B. Pharmaceutical statistics practical and clinical applications, Marcel Dekker, 4th edi.2004, 215-220. 65. Dunnet C. and Goldsmith C., in Statistics in the Pharmaceutical Industry, 2nd ed., C. R.Buncher and J. -Y. Tsay, Eds., Marcel Dekker, New York, 1993. 66. Snedecor G. W. and Cochran, W. G., Statistical Methods, 8th ed., Iowa State University Press,Ames, Iowa, 1989. 67. Altman D.G. Practical statistics for medical research. Chapman and Hall, London, (1991) pp. 210-211. 68. Mogili R, Kanala K, Bannoth C, Chandu B,and Reddy B. Quantification of Esomeprazole in Human plasma by Liquid Chromatography Tandem Mass Spectrometry and its Application to Bioequivalence Study. Der Pharmacia Lettre; 2011: 3 (5)138-145. 69. Hassan-alli M., Andersson T., Bredberge E., Rohss K., Pharmacokinetics of Esomeprazole after oral and intravenous administration of single and repeated doses to healthy subjects. Europien journal of clinical pharmacology; 2000, 56, 665-670. 70. Onal A., Oztunç A. Development and validation of high performance liquid chromatographic method for the determination of esomeprazole in tablets. J. Food Drug Anal., Vol. 14, No. 1, 2006, pp 12-18. 71. Hultman I., Stenhoff H., Mathias L. Determination of Esomeprazole and its two main metabolites in human, rat and dog plasma by liquid chromatography with tandem mass spectrometry. Journal of Chromatography B; 2007, 848(2), 317-322. 72. June Z., Juingao Li., Jenifer E., Anderson T., Fulmer R., Illeuca M., Lundberg P.
Pharmacokinetic properties of Esomeprazole in children aged 1 to 11 years with symptoms of gastro esophageal reflux disease : A randomized, open-label study. Clincal Therapeutics; 2006, 28, 1868-1876. 73. Patil SS, Dhabale PN , Kuchekar BS. Development and statistical validation of Spectrophotometric Method for Estimation of Esomeprazole in Tablet Dosage Form; Asian J Research Chem 2009; 2(2);154-156.
––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––– L.J.I.P Kadi Sarva Vishwavidyalaya 134
Maheshwari D.G.
74. Nafisur R, Zehra B , Syed N H.
References
Spectrophotometric Determination of Esomeprazole
magnesium in Commercial Tablets Using 5-Sulfosalicylic Acid and N-Bromosuccinimide. J Chinese Chem Soc 2008; 55(3):557-566. 75. Pardeep K, Subrahmanya G,. Development and validation of derivative spectrophotometric method for simultaneous estimation of domperidone and esomeprazole. International Journal of Universal Pharmacy and Life Sciences 1(2): (2011)9-15. 76. Lakshmana PS ,Shirwaiker A, kumar DC, Joseph A , Kumar R .Simultaneous estimation of Esomeprazole and Domperidone by UV Spectrophotometric Method. Indian J Pharm Sci 2008; 77(1);128-131. 77. Okram Z., kanakapura B., basavaiah V. Simple and selective spectrophotometric methods
for the determination of domperidone in pharmaceuticals through charge transfer complex formation reaction, turki j. pharm. sci. ; 2012,9 (1), 27-40. 78. Rajendraprasad Y, Rajasekhar KK, Shankarananth V, Kumar S, a simple RP-HPLC method for the estimation of domperidone in bulk and pharmaceutical formulations.
Asian
Journal of Research in Chemistry; 2009, 2(4), 561-564. 79. Zhuang R and Li, Shuli Yiyaoxue Zazhi. HPLC method for content and uniformity determination of domperidone tablets; 2009, 22(4), 487-488. 80. Sivasubramanian L, Anilkumar V. RP-HPLC method for the determination of omeprazole and domperidone from tablet formulations. Indian Journal of Pharmaceutical Sciences; 2007, 69 (5), 674-676. 81. Kalure S, Kulkarni R, Somwanshi G. Spectrophotometric simultaneous determination of domperidone and pantoprazol in pharmaceutical preparations. Der Pharma Chemica; 2012, 4(4):1517-1521. 82. Sawant R, Bhangale L, Joshi R and Lanke P. Validated spectrophotometric methods for simultaneous estimation of Paracetamol, Domperidone and Tramadol HCl in pure and tablet dosage form. J. Chem. Metrol; 4:1 (2010) 21-27. 83. Santhosha B, Ravindranath A, Sundari C. Stability indicating Rp-hplc method for the simultaneous estimation of domperidone and lafutidine in bulk and the pharmaceutical dosage form. Int J Pharm Pharm Sci; Vol 4, Suppl 4, 589-594. ––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––– L.J.I.P Kadi Sarva Vishwavidyalaya 135
Maheshwari D.G.
References
84. Tarkase K, Tarkase M, Dokhe M and Wagh V. Development and validation of spectrophotometric method for simultaneous estimation of cinnarizine and domperidone maleate in pure and tablet dosage form. IJPSR, 2012; Vol. 3(8): 2700-2704. 85. Hartman W, Karnik S. Quantitative determination of Granisetron in human plasma using LC/MS/MS. Location: M1096, 2006 AAPS Annual Meeting and Exposition; 2006. 86. Nirogi RVS, Kandikere VN, Shukla M, Koteshwara. Quantification of Granisetron in human plasma by liquid chromatography coupled to electrospray tandem mass spectrometry. Biomedical Chromatography; 2006, 20(9): 888-897. 87. Pinguet F, Bressolle F, Martel P, Salabert D, Astre C. High performance liquid chromatographic
determination
of
Granisetron
in
human
plasma.
Journal
of
Chromatography B; 1996, 675(1): 99-105. 88. Kudoh S, Sato T, Okada H, Kumakura H, Nakamura H. Simultaneous determination of Granisetron and its 7-hydroxy metabolite in human plasma by high performance liquid chromatography with fluorescence detection. Journal of Chromatography B; 1994, 660(1): 205-210. 89. Boppana VK. Simultaneous determination of Granisetron and its 7-hydroxy metabolite in human plasma by reversed phase high performance liquid chromatography utilizing fluorescence and electrochemical detection. Journal of Chromatography A; 1995, 692(1-2): 195-202. 90. Xiang DY, Le LK, Zhang JX. HPLC determination of Granisetron in human plasma. Chinese Pharmaceutical Journal; 2002, 22(11): 661-664. 91. Jiang Y, Lin M, Fan G, Chen Y, Li Z, Zhao W, Wu Y, Hu J. Rapid determination of Granisetron in human plasma by liquid chromatography coupled to tandem mass spectrometry and its application to bioequivalence study. Journal of Pharmaceutical and Biomedical Analysis; 2006; 42(4): 464-473. 92. Boppana VK, Stein CM, Schaefer WH. Direct plasma liquid chromatographic-tendam mass spectrometric analysis of Granisetron and its 7-hydroxy metabolite using internal surface reversed phase guard columns and automated column switching devices. Journal of ––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––– L.J.I.P Kadi Sarva Vishwavidyalaya 136
Maheshwari D.G.
References
Chromatography B; 1996; 678(2): 227-236. 93. Wada I, Satoh M, Takeda T, Nakabayashi T, Honma T, Saitoh H. A rapid assay of Granisetron in biological fluids from cancer patients. Biological and Pharmaceutical Bulletin; 1998; 21(5): 535-537. 94. Zhang H, Ye L, Stewart JT. HPLC determinations of Doxorubicin with selected medications in 0.9% sodium chloride injection USP. Journal of Liquid Chromatography and Related Technologies; 1998; 21(15): 2375-2385. 95. El-Gindy A., El-Yazby F., Mustafa M. Spectrophotometric and chromatographic determination of Rabeprazole in presence of its degradation products. Journal of pharmaceutical and bioanalysis; 2003, 31(2), 229-242. 96. Bhavesh H., Madhabhai M., Jignesh R.,Bhanubhai N. HPLC Analysis for Simultaneous Determination of Rabeprazole and Domperidone in Pharmaceutical Formulation. Journal of Liquid Chromatography & Related Technologies; 2007, 30 (3), 439 – 445. 97. Tsukasa U., Norio Y., Mikiko S., Kazunobu S.,Tomonori T. Determination of Rabeprazole and its active metabolite, Rabeprazole thioether in human plasma by column-switching highperformance liquid chromatography and its application to pharmacokinetic study Journal of Chromatography B; 2005, 824(1), 238-243. 98. Garcia S.,, Cássia S., Juliana S., Leticia G, Silvia S i., André S., Martin S., Elfrides S. Validation of a Capillary Electrophoresis Method for Analysis of Rabeprazole Sodium in a Pharmaceutical Dosage Form. Journal of AOAC international; 2005, 44, 88. 99. Garcia C., Sippel J., Steppe M., Schapoval E. Development and Validation of Derivative Spectrophotometric Method for Determination of Rabeprazole Sodium in Pharmaceutical Formulation . Analytical Letters; 2006, 39 (2), 341 – 348. 100.
Jinchang H., Yu X., Shu G., Lei Ri., Qingxiang G. Development of a liquid
chromatography/tandem mass spectrometry assay for the quantification of Rabeprazole in human plasma. Rapid communications in mass spectrometry; 2005, 19, 2321-2324. 101.
Ramakrishna S., Vishwottam K., Wishu S., Koteshwara M., Suresh Kumar S. High-
performance liquid chromatography method for the quantification of Rabeprazole in human plasma using solid-phase extraction. Journal of Chromatography B;2005, 209-214 . ––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––– L.J.I.P Kadi Sarva Vishwavidyalaya 137
Maheshwari D.G.
102.
References
Pressankumaran P.,Mary A. Estimation of Rabeprazole using HPTLC. 56th IPC; 2004,
Abstract No. GP-48. 103.
Kalirajan R, Anandarajagopal K., Mathew S., Gowramma B., Jubie S.,and Suresh B.
simultaneous determination of rabeprazole and domperidone in dosage forms by rp-hplc. rasayan j. chem; 2008, vol.1, no.2 ,232-235. 104.
Shobha manjunath, venkatesh chouhan, s.sandeep. spectrophotometric estimation of
levosulpiride in bulk drug and formulations international journal of pharmacy and pharmaceutical sciences; 2011, vol 3, issue 2, 135-137. 105.
S.p. silambarasan, k. anandakumar, r. venkatalakshmi and c. sasikala, development of uv
spectrophotometry and rp-hplc methods for the estimation of levosulpiride in bulk and in tablet formulation; 2010, volume 03, issue 03, 542-546.
––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––– L.J.I.P Kadi Sarva Vishwavidyalaya 138
